Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna ’s Vaccine (mRNA-1273) Against Novel Coronavirus

CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--May 1, 2020-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials